Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-25-196313

Chief Executive Officer sold 40,000 shares at an average $70.53 ($2,821,033)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BELANOFF JOSEPH K · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-02 Sale : show line 1 in the form 10b5-1 −39,300 $70.52 $2,771,326 2,822,070 I
2025-09-02 Sale : show line 2 in the form 10b5-1 −700 $71.01 $49,707 2,821,370 I
Open-market sales · 40,000 sh · avg $70.53 · $2,821,033
Loading xslF345X05/ownership.xml…